Malignant abdominal mesothelioma

Defining the role of surgery

Dayron Rodríguez, Michael C. Cheung, Nadine Housri, Leonidas Koniaris

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: Determine the role of surgery for patients with malignant abdominal mesotheliomas (MAMs). Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, 10,589 cases of malignant mesotheliomas were identified. Of these, 9,211 cases were thoracic (TM) and 1,112 cases were MAM (10.5%). Patients with TM presented with more localized disease than those patients with MAM (P <0.001). MAM more often affected younger patients (63 years vs. 71 years) (P <0.001). The annual incidence of MAM was approximately 1.00 case per 100,000 in 2005. Overall median survival for MAM patients was 8 months, with a significant difference between women and men (13 months vs. 6 months, respectively) (P <0.001). Patients who successfully underwent surgical resection had a considerably longer median survival (20 months vs. 4 months, P <0.001) as well as a significantly higher 5-year survival (28% vs. 12%, P <0.001). Multivariate analysis identified that a poorly differentiated tumor grade, failure to undertake surgical resection, advanced age, and male gender were all independent predictors of poorer outcome. Conclusion: Surgical extirpation of MAM may be associated with significantly improved survival. All patients with MAM should be evaluated for potential surgical resection.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalJournal of Surgical Oncology
Volume99
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Survival
Malignant Mesothelioma
Epidemiology
Thorax
Multivariate Analysis
Databases
Incidence
Neoplasms
TM 1

Keywords

  • Abdominal mesothelioma
  • Cancer
  • Malignancy
  • Outcomes
  • Peritoneal mesothelioma
  • Pleural mesothelioma
  • SEER
  • Surgery
  • Survival
  • Thoracic mesothelioma

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Malignant abdominal mesothelioma : Defining the role of surgery. / Rodríguez, Dayron; Cheung, Michael C.; Housri, Nadine; Koniaris, Leonidas.

In: Journal of Surgical Oncology, Vol. 99, No. 1, 01.01.2009, p. 51-57.

Research output: Contribution to journalArticle

Rodríguez, Dayron ; Cheung, Michael C. ; Housri, Nadine ; Koniaris, Leonidas. / Malignant abdominal mesothelioma : Defining the role of surgery. In: Journal of Surgical Oncology. 2009 ; Vol. 99, No. 1. pp. 51-57.
@article{db2c5e2910eb49639f629fb2495a76be,
title = "Malignant abdominal mesothelioma: Defining the role of surgery",
abstract = "Objective: Determine the role of surgery for patients with malignant abdominal mesotheliomas (MAMs). Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, 10,589 cases of malignant mesotheliomas were identified. Of these, 9,211 cases were thoracic (TM) and 1,112 cases were MAM (10.5{\%}). Patients with TM presented with more localized disease than those patients with MAM (P <0.001). MAM more often affected younger patients (63 years vs. 71 years) (P <0.001). The annual incidence of MAM was approximately 1.00 case per 100,000 in 2005. Overall median survival for MAM patients was 8 months, with a significant difference between women and men (13 months vs. 6 months, respectively) (P <0.001). Patients who successfully underwent surgical resection had a considerably longer median survival (20 months vs. 4 months, P <0.001) as well as a significantly higher 5-year survival (28{\%} vs. 12{\%}, P <0.001). Multivariate analysis identified that a poorly differentiated tumor grade, failure to undertake surgical resection, advanced age, and male gender were all independent predictors of poorer outcome. Conclusion: Surgical extirpation of MAM may be associated with significantly improved survival. All patients with MAM should be evaluated for potential surgical resection.",
keywords = "Abdominal mesothelioma, Cancer, Malignancy, Outcomes, Peritoneal mesothelioma, Pleural mesothelioma, SEER, Surgery, Survival, Thoracic mesothelioma",
author = "Dayron Rodr{\'i}guez and Cheung, {Michael C.} and Nadine Housri and Leonidas Koniaris",
year = "2009",
month = "1",
day = "1",
doi = "10.1002/jso.21167",
language = "English (US)",
volume = "99",
pages = "51--57",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Malignant abdominal mesothelioma

T2 - Defining the role of surgery

AU - Rodríguez, Dayron

AU - Cheung, Michael C.

AU - Housri, Nadine

AU - Koniaris, Leonidas

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Objective: Determine the role of surgery for patients with malignant abdominal mesotheliomas (MAMs). Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, 10,589 cases of malignant mesotheliomas were identified. Of these, 9,211 cases were thoracic (TM) and 1,112 cases were MAM (10.5%). Patients with TM presented with more localized disease than those patients with MAM (P <0.001). MAM more often affected younger patients (63 years vs. 71 years) (P <0.001). The annual incidence of MAM was approximately 1.00 case per 100,000 in 2005. Overall median survival for MAM patients was 8 months, with a significant difference between women and men (13 months vs. 6 months, respectively) (P <0.001). Patients who successfully underwent surgical resection had a considerably longer median survival (20 months vs. 4 months, P <0.001) as well as a significantly higher 5-year survival (28% vs. 12%, P <0.001). Multivariate analysis identified that a poorly differentiated tumor grade, failure to undertake surgical resection, advanced age, and male gender were all independent predictors of poorer outcome. Conclusion: Surgical extirpation of MAM may be associated with significantly improved survival. All patients with MAM should be evaluated for potential surgical resection.

AB - Objective: Determine the role of surgery for patients with malignant abdominal mesotheliomas (MAMs). Methods: The Surveillance, Epidemiology, and End Results (SEER) database (1973-2005) was queried. Results: Overall, 10,589 cases of malignant mesotheliomas were identified. Of these, 9,211 cases were thoracic (TM) and 1,112 cases were MAM (10.5%). Patients with TM presented with more localized disease than those patients with MAM (P <0.001). MAM more often affected younger patients (63 years vs. 71 years) (P <0.001). The annual incidence of MAM was approximately 1.00 case per 100,000 in 2005. Overall median survival for MAM patients was 8 months, with a significant difference between women and men (13 months vs. 6 months, respectively) (P <0.001). Patients who successfully underwent surgical resection had a considerably longer median survival (20 months vs. 4 months, P <0.001) as well as a significantly higher 5-year survival (28% vs. 12%, P <0.001). Multivariate analysis identified that a poorly differentiated tumor grade, failure to undertake surgical resection, advanced age, and male gender were all independent predictors of poorer outcome. Conclusion: Surgical extirpation of MAM may be associated with significantly improved survival. All patients with MAM should be evaluated for potential surgical resection.

KW - Abdominal mesothelioma

KW - Cancer

KW - Malignancy

KW - Outcomes

KW - Peritoneal mesothelioma

KW - Pleural mesothelioma

KW - SEER

KW - Surgery

KW - Survival

KW - Thoracic mesothelioma

UR - http://www.scopus.com/inward/record.url?scp=58149384916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149384916&partnerID=8YFLogxK

U2 - 10.1002/jso.21167

DO - 10.1002/jso.21167

M3 - Article

VL - 99

SP - 51

EP - 57

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -